Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials

Stopped early · Phase 2

Conditions studied: Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma

In brief

This is an open label compassionate use trial of Ublituximab and TGR-1202 in combination or as single agents in patients currently receiving treatment on Ublituximab and/or TGR-1202 trials with B-cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia.

Key facts

Study ID

NCT03207256

Run by

TG Therapeutics, Inc.

People needed

51

Starts

2017-08-09

Expected to finish

2022-06-24

Last updated by the study team

2022-07-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be currently receiving treatment with ublituximab and/or TGR-1202 on a previously approved protocol.
• Subjects must have completed at least 6 cycles of therapy on their current protocol.

You may not qualify if…

• Subject progressed while receiving therapy with ublituximab and/or TGR-1202 while participating in their immediate previous trial.

Where it is running

• TG Therapeutics Investigational Trial Site — Huntsville, Alabama, United States
• TG Therapeutics Investigational Trial Site — Tucson, Arizona, United States
• TG Therapeutics Investigational Trial Site — Fayetteville, Arkansas, United States
• TG Therapeutics Investigational Trial Site — Duarte, California, United States
• TG Therapeutics Investigational Trial Site — Fort Myers, Florida, United States
• TG Therapeutics Investigational Trial Site — Atlanta, Georgia, United States
• TG Therapeutics Investigational Trial Site — Fort Wayne, Indiana, United States
• TG Therapeutics Investigational Trial Site — Coon Rapids, Minnesota, United States
• TG Therapeutics Investigational Trial Site — Omaha, Nebraska, United States
• TG Therapeutics Investigational Trial Site — Durham, North Carolina, United States
• TG Therapeutics Investigational Site — Canton, Ohio, United States
• TG Therapeutics Investigational Trial Site — Cincinnati, Ohio, United States
• TG Therapeutics Investigational Trial Site — Nashville, Tennessee, United States
• TG Therapeutics Investigational Trial Site — Denton, Texas, United States
• TG Therapeutics Investigational Trial Site — San Antonio, Texas, United States
• TG Therapeutics Investigational Trial Site — Seattle, Washington, United States
• TG Therapeutics Investigational Trial Site — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.